Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Clinical significance of tumor-infiltrating lymphocytes in breast cancer

Fig. 1

Most breast cancers have evidence of lymphocytic infiltrates at the time of diagnosis, although the level of infiltrate is modest, and the presence of CD8+ infiltrate varies between the breast cancer subtypes. The % individuals (x-axis) are shown for: a no evidence of TIL (white), TIL <50 % (medium grey), and LBPC (black) data compiled from 6 studies. *Only one to two studies evaluated no infiltrate separately. b Presence of CD8+ infiltrate (black) or no CD8+ infiltrate (white), data compiled from 3 studies

Back to article page